Tracer library / [11C]PiB
Structure of Pittsburgh compound B (unlabelled parent compound, from PubChem)
Unlabelled parent compoundPubChem CID 10171487

[11C]PiB

Also written as 2-(4-N-[11C]methylaminophenyl)-6-hydroxybenzothiazole; [11C]PIB; [C-11]PIB; C-11 PIB; C-11-PIB; PIB; Pittsburgh compound B
Radionuclide
C-11 t½ 20.4 min
Modality
PET
Production route
Cyclotron liquid target
Stage
Clinical research
Syntheses indexed
17

What it is

Compound class
Benzothiazole
Target / mechanism
Fibrillar amyloid-beta plaques PMID 23757761 / DOI 10.1093/brain/awt142
Clinical application
Alzheimer's disease research; amyloid quantification PMID 23757761 / DOI 10.1093/brain/awt142
Theranostic pair
—

Regulatory status

FDA
No Drugs@FDA / openFDA drug registry — no approved application found; search: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process&searchTerm=Pittsburgh+compound+B
EMA (centralised)
—
Other approvals
—
Brand names
—

Published syntheses

ModuleCassettePurificationYield %RCP %Precursor / supplierSource
FASTlab
GE HealthCare
custom manifoldSPE—>98%6-OH-BTA-0
Advanced Biochemical Compounds, ABX, Germany
38154168
2024 Nucl Med Biol
The GE FASTlab developer system was used to create the cassette design as well as the controlling tracer package.
FASTlab
GE HealthCare
custom manifoldSPE—>98%6-OH-BTA-0
Advanced Biochemical Compounds, ABX, Germany
38154168
2024 Nucl Med Biol
The GE FASTlab developer system was used to create the cassette design as well as the controlling tracer package.
TRACERlab FX C Pro
GE HealthCare
fixed tubingHPLC——6-OH-BTA-0
LIMBP, Université P. Verlaine, Metz, France
38399432
2024 Pharmaceuticals (Basel)
Synthesis was carried out on a TracerLab FX C Pro automated synthesis module.
TracerMaker
Scansys Laboratorieteknik
fixed tubingHPLC——6-OH-BTA-0
ABX
38399432
2024 Pharmaceuticals (Basel)
The automated [11C]PiB radiosynthesis and product isolation was performed on a TracerMaker synthesis module (Scansys Laboratorieteknik ApS, Denmark)
TRACERlab FX C Pro
GE HealthCare
fixed tubingHPLC——6-OH-BTA-0
ABX
38399432
2024 Pharmaceuticals (Basel)
The automated [11C]PiB production and product purification processes were performed on a Tracerlab FXc (GE HealthCare, Uppsala, Sweden)
ScanSys synthesizer
Scansys Laboratorieteknik
fixed tubingHPLC——6-OH-BTA-0
ABX
38399432
2024 Pharmaceuticals (Basel)
The automated [11C]PiB production process was performed on either a ScanSys or TracerMaker module (Scansys Laboratorieteknik ApS, Vaerloese, Denmark)
TracerMaker
Scansys Laboratorieteknik
fixed tubingHPLC——6-OH-BTA-0
ABX
38399432
2024 Pharmaceuticals (Basel)
The automated [11C]PiB production process was performed on either a ScanSys or TracerMaker module (Scansys Laboratorieteknik ApS, Vaerloese, Denmark)
AllinOne (AiO)
Trasis
vendor cassetteHPLC+SPE9.8 ± 1.7%
not corrected
>99%6-OH-BTA-0
ABX
37788544
2023 Appl Radiat Isot
using the Trasis AllinOne synthesis unit, a commonly used commercial radiochemistry module - The average non-decay-corrected yield using the Trasis method was 9.8 ± 1.7% (calculated from trapped [11C]CO2).
TRACERlab FX C Pro
GE HealthCare
—HPLC+SPE14.8
decay-corrected
956-OH-BTA-0
Siquimia
31659494
2019 EJNMMI Radiopharm Chem
TRACERlab® FX C PRO module (GE Healthcare) - The radiochemical yield and activity (EOS) of formulated [11C] PiB from cyclotron-produced [11C]CO2 was (14.8 ± 12.1)%, decay corrected)
TRACERlab FX C Pro
GE HealthCare
—HPLC+SPE7
decay-corrected
—6-OH-BTA-0
Siquimia
31659494
2019 EJNMMI Radiopharm Chem
TRACERlab® FX C PRO module (GE Healthcare) - an average activity of [11C] PiB (EOS) of about 3.14 GBq (RCY 7%, dc)
TracerMaker
Scansys Laboratorieteknik
—————42140884
2026 J Labelled Comp Radiopharm
a fully automated TracerMaker radiosynthesizer for routine production of multiple 11C-labeled PET tracers
CFN-MPS100
Sumitomo
—SPE40±5%
decay-corrected
>97%—38454773
2024 Curr Radiopharm
fully automated radiosynthesis of [11C]PiB in a commercially available synthesizer, MPS-100 (SHI, Japan) - decay-corrected radiochemical yield of 40±5%
In-house / custom built
Laboratory
—SPE22%
not corrected
——28981146
2017 J Labelled Comp Radiopharm
we report a novel, highly efficient solid phase supported carbon-11 radiolabeling procedure using commercially available disposable tC18 cartridge as a "3-in-1" entity: reactor, purifier, and solvent replacement system - in 22% isolated yield not corrected for decay
——HPLC—>98%—26248085
2015 Appl Radiat Isot
TRACERlab FX C Pro
GE HealthCare
——32.9 ± 6.6
decay-corrected
>99%6-OH-BTA-021897309
2011 Nucl Med Commun
[\u00b9\u00b9C]methyl iodide and [\u00b9\u00b9C]methyl triflate were produced in the TRACERlab FXC Pro synthesis box. Methylation reactions and the final formulation were performed using the AutoLoop (captive solvent method) and the ReFORM-plus systems, respectively. - Good radiochemical yields (51.3 \u00b1 11.2 and 32.9 \u00b1 6.6%, referred to as [\u00b9\u00b9C]methyl iodide, decay corrected)
———48.0±2.7%
decay-corrected
>99%—21550258
2011 Appl Radiat Isot
——HPLC13+/-15%>99%2-(4'-aminophenyl)-6-hydroxybenzothiazole18769311
2008 Nucl Med Commun
we reported the first fully automated synthesis of [11C]PIB with the coupling of two commercial synthesizers - resulting in a total radiochemical yield of 13+/-15% after a synthesis time of 25 min

Clinical literature

Clinical studies in the indexed corpus, ordered by design (multicentre, prospective, retrospective, others, case reports last) and then by year. Titles and links only, as published; this is not a summary of the evidence.

  1. Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease.
    2017 · JAMA Neurol · Clinical study
  2. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
    2016 · J Nucl Med · Clinical study
  3. Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data.
    2009 · Eur J Nucl Med Mol Imaging · Clinical study
  4. Voxel-based analysis of 11C-PIB scans for diagnosing Alzheimer's disease.
    2008 · J Nucl Med · Clinical study

Precursor

Common precursor
6-OH-BTA-0 (desmethyl-PiB) PMID 38399432 / DOI 10.3390/ph17020217
Suppliers seen in the literature
6-OH-BTA-0 (desmethyl) precursor from ABX advanced biochemical compounds (Radeberg, Germany) or Pharmasynth AS (Tartu, Estonia)
Cited suppliers in indexed syntheses
ABX, Advanced Biochemical Compounds, LIMBP, Université P. Verlaine, Siquimia
Typical final purification
—

Need this precursor?We can point you to suppliers for [11C]PiB, or handle the enquiry for you.

Get in touch

Quality control Derived from the published synthesis

Ph. Eur. monograph
no monograph none (general monograph 0125 applies)
USP monograph
not verified the USP-NF monograph index is subscription-only and no public confirmation was found
AppearancepHRCP HPLCHPLC UVResidual solvents (GC)Radionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrityMolar activity
How this set was arrived at. Cross-checked against Ph. Eur. general monograph 0125 (base set), EANM validation guideline (PMC7016057) and cGRPP guidance (PMC7881071). Draft X-marks consistent with the base set; tracer-specific analytical tests follow the specific monograph where one exists.

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [11C]PiB.

Get in touch

Notes

Short half-life restricts use to sites with an on-site cyclotron.
Ask a question